Apr 7, 2026 07:44AM
Mar 24, 2026 08:30AM
Mar 24, 2026 08:30AM
Jan 12, 2026 06:51AM
Sep 15, 2025 07:38AM
Sep 11, 2025 08:01AM
Sep 11, 2025 08:00AM Enlivex CEO Issues Letter to Shareholders Outlining Strategic Roadmap Following Positive Phase IIa Allocetra™ Results
Apr 24, 2025 07:10AM
Mar 24, 2025 06:42AM
Sep 27, 2024 06:51AM
Sep 9, 2024 06:43AM
Jun 11, 2024 06:42AM
May 28, 2024 08:12AM
May 28, 2024 08:12AM Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
Sep 7, 2023 08:00AM
Apr 14, 2023 09:40AM
Sep 13, 2022 08:00AM
May 19, 2022 08:00AM
Sep 9, 2021 08:00AM
Mar 9, 2021 08:00AM
Feb 18, 2021 08:00AM Enlivex Announces Exercise of Underwriter’s Option to Purchase Additional Shares
Feb 18, 2021 08:00AM
Feb 12, 2021 05:21PM
Feb 12, 2021 05:21PM
Feb 10, 2021 06:25AM
Feb 9, 2021 11:24PM
Feb 9, 2021 11:24PM
Feb 9, 2021 05:26PM Enlivex Therapeutics Ltd. (ENLV) Announces $10 Million Bought Deal Offering of Ordinary Shares
Feb 9, 2021 05:25PM
Feb 9, 2021 05:25PM
Jan 11, 2021 08:00AM
Nov 11, 2020 08:14AM
Aug 25, 2020 09:30AM
Mar 5, 2020 08:15AM
Mar 5, 2020 08:15AM Enlivex Therapeutics Closes $16.75 Million Registered Direct Offering
Mar 2, 2020 08:02AM
Mar 2, 2020 08:00AM
Mar 2, 2020 08:00AM
Feb 26, 2020 01:46PM
Feb 26, 2020 01:45PM
Feb 24, 2020 03:01PM
Feb 24, 2020 01:54PM Enlivex Therapeutics Announces $8.0 Million Registered Direct Offering
Feb 24, 2020 01:54PM
Jan 9, 2020 07:16AM
Sep 4, 2019 07:30AM
Sep 4, 2019 07:30AM
Apr 4, 2019 09:31AM
Apr 4, 2019 09:31AM

21,351 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All